687.00
-29.00
(-4.05%)
At close: January 2 at 10:13:08 AM GMT+1
Key Executives
Key Executives Information Not Available
REGENERON PHARMACEUTICALS
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
REGENERON PHARMACEUTICALS’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
February 4, 2025 at 1:30 PM UTC
REGENERON PHARMACEUTICALS Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
0K4.F Akero Therapeutics, Inc.
25.36
+0.71%
0MGB.IL Genmab A/S
1,601.75
+0.28%
1VT.BE Viking Therapeutics Inc
38.60
-3.67%
ORKA Oruka Therapeutics, Inc.
15.72
-17.31%
LIPO Lipella Pharmaceuticals Inc.
2.9000
-8.52%
HRMY Harmony Biosciences Holdings, Inc.
33.86
-1.94%
URGN UroGen Pharma Ltd.
10.24
-7.25%
PCVX Vaxcyte, Inc.
81.08
+0.02%
MRUS Merus N.V.
43.85
+3.84%
KOD Kodiak Sciences Inc.
8.32
-9.57%